Cita APA

Tran, H. C., Wan, Z., Sheard, M. A., Sun, J., Jackson, J. R., Malvar, J., . . . Seeger, R. C. (2016). TGFβR1 Blockade with Galunisertib (LY2157299) Enhances Anti-Neuroblastoma Activity of Anti-GD2 Antibody Dinutuximab (ch14.18) with Natural Killer Cells. Clin Cancer Res.

Citación estilo Chicago

Tran, Hung C., et al. "TGFβR1 Blockade With Galunisertib (LY2157299) Enhances Anti-Neuroblastoma Activity of Anti-GD2 Antibody Dinutuximab (ch14.18) With Natural Killer Cells." Clin Cancer Res 2016.

Cita MLA

Tran, Hung C., et al. "TGFβR1 Blockade With Galunisertib (LY2157299) Enhances Anti-Neuroblastoma Activity of Anti-GD2 Antibody Dinutuximab (ch14.18) With Natural Killer Cells." Clin Cancer Res 2016.